MARIETTA, Ga., March 26, 2018 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced positive pain and foot function results from its Phase 2Bclinical trial of AmnioFix® Injectable in the treatment of Plantar Fasciitis. The Phase 2B IND clinical trial evaluating the use of AmnioFix Injectable for the treatment of […]